Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Mallinckrodt
Fish and Richardson
Johnson and Johnson
Medtronic
Express Scripts
McKinsey
Farmers Insurance
Teva

Generated: April 27, 2018

DrugPatentWatch Database Preview

BACITRACIN-NEOMYCIN-POLYMYXIN Drug Profile

« Back to Dashboard

When do Bacitracin-neomycin-polymyxin patents expire, and when can generic versions of Bacitracin-neomycin-polymyxin launch?

Bacitracin-neomycin-polymyxin is a drug marketed by Pharmaderm, Altana, and Perrigo Co Tennessee. and is included in three NDAs.

The generic ingredient in BACITRACIN-NEOMYCIN-POLYMYXIN is bacitracin zinc; hydrocortisone acetate; neomycin sulfate; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the bacitracin zinc; hydrocortisone acetate; neomycin sulfate; polymyxin b sulfate profile page.
Summary for BACITRACIN-NEOMYCIN-POLYMYXIN
Drug patent expirations by year for BACITRACIN-NEOMYCIN-POLYMYXIN

US Patents and Regulatory Information for BACITRACIN-NEOMYCIN-POLYMYXIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmaderm BACITRACIN-NEOMYCIN-POLYMYXIN bacitracin zinc; neomycin sulfate; polymyxin b sulfate OINTMENT;OPHTHALMIC 062167-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Altana BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE bacitracin; hydrocortisone acetate; neomycin sulfate; polymyxin b sulfate OINTMENT;OPHTHALMIC 060731-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Perrigo Co Tennessee BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE bacitracin zinc; hydrocortisone acetate; neomycin sulfate; polymyxin b sulfate OINTMENT;OPHTHALMIC 062166-002 Approved Prior to Jan 1, 1982 RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Argus Health
Fuji
Mallinckrodt
Cipla
Cerilliant
Covington
Chubb
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.